Success Metrics

Clinical Success Rate
88.5%

Based on 46 completed trials

Completion Rate
88%(46/52)
Active Trials
16(17%)
Results Posted
39%(18 trials)
Terminated
6(6%)

Phase Distribution

Ph phase_4
20
21%
Ph early_phase_1
2
2%
Ph not_applicable
22
23%
Ph phase_1
10
11%
Ph phase_2
12
13%
Ph phase_3
19
20%

Phase Distribution

12

Early Stage

12

Mid Stage

39

Late Stage

Phase Distribution85 total trials
Early Phase 1First-in-human
2(2.4%)
Phase 1Safety & dosage
10(11.8%)
Phase 2Efficacy & side effects
12(14.1%)
Phase 3Large-scale testing
19(22.4%)
Phase 4Post-market surveillance
20(23.5%)
N/ANon-phased studies
22(25.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.7%

46 of 57 finished

Non-Completion Rate

19.3%

11 ended early

Currently Active

16

trials recruiting

Total Trials

95

all time

Status Distribution
Active(23)
Completed(46)
Terminated(11)
Other(15)

Detailed Status

Completed46
unknown15
Recruiting12
Terminated6
Withdrawn5
Not yet recruiting5

Development Timeline

Analytics

Development Status

Total Trials
95
Active
16
Success Rate
88.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.4%)
Phase 110 (11.8%)
Phase 212 (14.1%)
Phase 319 (22.4%)
Phase 420 (23.5%)
N/A22 (25.9%)

Trials by Status

withdrawn55%
completed4648%
not_yet_recruiting55%
enrolling_by_invitation22%
terminated66%
unknown1516%
recruiting1213%
active_not_recruiting44%

Recent Activity

Clinical Trials (95)

Showing 20 of 95 trialsScroll for more
NCT06780085Phase 2

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Recruiting
NCT05660421Phase 2

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Withdrawn
NCT07546097Phase 4

Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT)

Recruiting
NCT04381936Phase 3

Randomised Evaluation of COVID-19 Therapy

Recruiting
NCT07513142Phase 4

PPP Versus Corticosteroid for Thigh Muscle Injuries

Enrolling By Invitation
NCT07474714Phase 3

Hyaluronic Acid Injection in Idiopathic Carpal Tunnel Syndrome; is it Effective as Local Corticosteroids

Not Yet Recruiting
NCT05844930Phase 4

A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder

Completed
NCT05789589Phase 1

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Recruiting
NCT07199192Phase 4

Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

Not Yet Recruiting
NCT05603468Phase 4

Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair

Active Not Recruiting
NCT07223580Phase 4

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Recruiting
NCT06712290Not Applicable

Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy

Withdrawn
NCT04477629Phase 2

Belatacept in De Novo Heart Transplantation

Recruiting
NCT06279078

Long-term Effect of Steroid on Metabolic Diseases in Asthmatics

Completed
NCT04843761Phase 3

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Completed
NCT06729606Phase 3

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Completed
NCT06729593Phase 3

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Completed
NCT04735185Not Applicable

Stem Cells vs. Steroids for Discogenic Back Pain

Withdrawn
NCT03752827Not Applicable

Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

Active Not Recruiting
NCT05400798Not Applicable

A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

Enrolling By Invitation

Drug Details

Intervention Type
DRUG
Total Trials
95